Exec Chat: Cognetivity’s Simple Brain Test Could Unlock Trillions In Health Care Savings
Executive Summary
Cognetivity Neuroscience’s CognICA tool uses a language and education-independent approach to assess whether a patient is exhibiting cognitive decline, so it could also aid drug discovery.
You may also be interested in...
Could Smart Watches And Phone Apps Detect Alzheimer’s Years Before Symptoms Present?
Investigational therapies are finally achieving some success in treating Alzheimer’s disease, but a cure is not yet in sight. Medtech now has a golden opportunity in pre-symptomatic detection, according to digital health tech research initiative, EDoN.
Digital Health Roundup: Digital Therapeutics, Restoring Function, Deals, Investing And Lobbying
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights the push behind digital therapeutics, Abbott’s biowearable line, Exec Chats with iRhythm and Cognetivity, Right To Repair rules for tech, and FDA's guidance on 3D-printing.
Finding A Rock ‘n Roll Moment In Dementia Diagnostics
Find a problem and develop the solution for it: so goes the accepted wisdom for successful health care technology adoption. But as Cognetivity Neurosciences CEO Sina Habibi demonstrates, the reverse can also provide a very valid business pathway.